Fidia Spa (FDA) Ratios

6 Followers

Fidia Spa Ratios

IT:FDA's free cash flow for Q2 2025 was €0.70. For the 2025 fiscal year, IT:FDA's free cash flow was decreased by € and operating cash flow was €-0.06. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	1.06	―	0.82	0.86	4.83
Quick Ratio	0.46	―	0.34	0.44	2.48
Cash Ratio	0.10	―	0.07	0.12	1.13
Solvency Ratio	-0.03	―	-0.32	>-0.01	1.69
Operating Cash Flow Ratio	-0.03	―	-0.18	-0.19	0.18
Short-Term Operating Cash Flow Coverage	-0.36	―	-4.28	-0.98	0.42
Net Current Asset Value	€ -4.02M	€ ―	€ -5.82M	€ -6.80M	€ 16.25M
Leverage Ratios
Debt-to-Assets Ratio	0.05	―	0.04	0.36	0.26
Debt-to-Equity Ratio	0.30	―	0.34	3.56	1.39
Debt-to-Capital Ratio	0.23	―	0.26	0.78	0.58
Long-Term Debt-to-Capital Ratio	0.00	―	0.00	0.28	0.00
Financial Leverage Ratio	6.26	―	9.61	10.00	5.39
Debt Service Coverage Ratio	-2.00	―	-5.65	0.08	3.45
Interest Coverage Ratio	-34.56	―	-16.55	-2.70	-13.46
Debt to Market Cap	24.23	―	<0.01	0.01	<0.01
Interest Debt Per Share	0.37	―	0.04	1.74	1.25
Net Debt to EBITDA	0.20	―	0.09	12.40	0.44
Profitability Margins
Gross Profit Margin	71.05%	―	74.17%	66.88%	5.94%
EBIT Margin	-14.98%	―	-50.25%	-2.15%	24.17%
EBITDA Margin	-12.01%	―	-43.80%	2.33%	31.31%
Operating Profit Margin	-14.84%	―	-37.58%	-5.76%	-21.81%
Pretax Profit Margin	-4.73%	―	-52.52%	-4.28%	22.77%
Net Profit Margin	-6.25%	―	-53.17%	-4.57%	24.49%
Continuous Operations Profit Margin	-6.94%	―	-54.31%	-5.15%	23.61%
Net Income Per EBT	132.24%	―	101.25%	106.69%	107.57%
EBT Per EBIT	31.87%	―	139.75%	74.33%	-104.37%
Return on Assets (ROA)	-4.45%	―	-32.85%	-4.06%	18.57%
Return on Equity (ROE)	-30.83%	―	-315.72%	-40.62%	100.02%
Return on Capital Employed (ROCE)	-29.81%	―	-148.33%	-25.27%	-19.10%
Return on Invested Capital (ROIC)	-26.28%	―	-120.70%	-14.35%	-17.89%
Return on Tangible Assets	-4.55%	―	-33.41%	-4.18%	19.17%
Earnings Yield	-8180.16%	―	-5.91%	-0.21%	0.57%
Efficiency Ratios
Receivables Turnover	4.45	―	3.94	5.21	3.45
Payables Turnover	1.14	―	0.80	1.58	4.16
Inventory Turnover	0.53	―	0.40	0.89	2.26
Fixed Asset Turnover	2.63	―	2.30	3.47	2.61
Asset Turnover	0.71	―	0.62	0.89	0.76
Working Capital Turnover Ratio	17.89	―	-4.34	4.47	4.31
Cash Conversion Cycle	451.09	―	556.22	250.10	179.60
Days of Sales Outstanding	81.98	―	92.72	70.05	105.86
Days of Inventory Outstanding	690.10	―	919.41	411.61	161.38
Days of Payables Outstanding	320.99	―	455.91	231.56	87.64
Operating Cycle	772.07	―	1.01K	481.66	267.24
Cash Flow Ratios
Operating Cash Flow Per Share	-0.13	―	-0.13	-0.70	0.11
Free Cash Flow Per Share	-0.17	―	-0.13	-0.77	0.07
CapEx Per Share	0.05	―	<0.01	0.07	0.04
Free Cash Flow to Operating Cash Flow	1.38	―	1.02	1.10	0.62
Dividend Paid and CapEx Coverage Ratio	-2.65	―	-40.21	-10.18	2.66
Capital Expenditure Coverage Ratio	-2.65	―	-40.21	-10.18	2.66
Operating Cash Flow Coverage Ratio	-0.36	―	-4.28	-0.42	0.10
Operating Cash Flow to Sales Ratio	-0.02	―	-0.25	-0.17	0.03
Free Cash Flow Yield	-2030.90%	―	-2.83%	-0.86%	0.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-0.02	―	-16.93	-472.04	174.84
Price-to-Sales (P/S) Ratio	<0.01	―	9.00	21.57	42.82
Price-to-Book (P/B) Ratio	<0.01	―	53.46	191.72	174.87
Price-to-Free Cash Flow (P/FCF) Ratio	-0.08	―	-35.37	-116.14	2.11K
Price-to-Operating Cash Flow Ratio	-0.05	―	-36.25	-127.55	1.32K
Price-to-Earnings Growth (PEG) Ratio	<0.01	―	-0.40	3.87	-0.77
Price-to-Fair Value	<0.01	―	53.46	191.72	174.87
Enterprise Value Multiple	0.18	―	-20.47	937.38	137.18
Enterprise Value	-412.16K	―	156.78M	625.23M	1.05B
EV to EBITDA	0.19	―	-20.47	937.38	137.18
EV to Sales	-0.02	―	8.97	21.86	42.96
EV to Free Cash Flow	0.68	―	-35.22	-117.70	2.11K
EV to Operating Cash Flow	0.94	―	-36.10	-129.26	1.32K
Tangible Book Value Per Share	1.02	―	0.07	0.36	3.84
Shareholders’ Equity Per Share	1.17	―	0.09	0.46	0.86
Tax and Other Ratios
Effective Tax Rate	-0.47	―	-0.03	-0.20	-0.04
Revenue Per Share	5.23	―	0.51	4.13	3.51
Net Income Per Share	-0.33	―	-0.27	-0.19	0.86
Tax Burden	1.32	―	1.01	1.07	1.08
Interest Burden	0.32	―	1.05	1.99	0.94
Research & Development to Revenue	<0.01	―	<0.01	<0.01	<0.01
SG&A to Revenue	0.42	―	0.16	0.07	0.05
Stock-Based Compensation to Revenue	0.00	―	0.00	0.00	0.00
Income Quality	0.38	―	0.46	3.70	0.13

Currency in EUR